Pangaea Data launches AI platform to support better patient outcomes and ease the pressure on global health systems 

AI health pioneer, Pangaea Data (Pangaea), is debuting its next-generation platform, designed to help clinicians close care gaps, find untreated and sub-optimally treated patients, and drive real improvement in patient outcomes.

Pangaea’s platform uses proven capabilities—already being deployed across 13 countries—to flag patients who are missing appropriate screening or treatments, despite relevant data being present in their records. This not only enables earlier diagnosis and more effective triaging of hard-to-diagnose conditions, but it helps health systems deliver more efficient care for better patient outcomes, according to the vendor.

Built to emulate clinical reasoning, the platform reviews patient conversations and medical records as a clinician would, but at scale, Pangea said. It analyzes both structured and unstructured data to identify missed diagnosis, treatment delays, incomplete referrals, and other care gaps often hidden despite information in the patient’s records.

Powered by advanced AI tools, the platform interprets all available patient information but also reasons to provide critical findings, for example, detecting care that is not concordant with established clinical guidelines. It integrates seamlessly with ambient listening tools, to capture further insights from consultations in real time. From there, the platform recommends or even automates next steps, such as scheduling follow-ups, thereby helping clinicians to act proactively without adding administrative burden.

By flagging these care gaps, based on guideline-driven insights, the platform enables earlier intervention, improving both patient outcomes and the overall care experience, Pangea said.

“We don’t just look at data, we bring the patient and their story to life,” said Dr. Vibhor Gupta, founder and CEO of Pangaea Data. “Patients who are at risk usually have their data in the system already, but what’s missing is a platform that sees the full picture and delivers the right insights, at the right time. By prioritizing what matters most, at the moment it matters, Pangaea empowers clinicians to act with confidence and specificity, avoid the alert fatigue so common with existing systems, and do all of this without adding to their workload.” 

Pangaea’s platform is fully embedded into existing electronic health records (EHR) systems, scheduling and referral tools, letting clinicians view the intelligence associated with care gaps identified by Pangaea in the context of a patient’s journey. 

Pangaea’s capabilities are already in use across prevalent and rare diseases such as Chronic Kidney Disease (CKD), Chronic Obstructive Pulmonary Disease (COPD), Cancer Cachexia, and rare conditions including Hypophosphatasia (HPP). The platform is demonstrating success at identifying untreated and sub-optimally treated patients across these conditions, according to Pangea.

The platform also found six times more cancer patients who were undiagnosed for cachexia and therefore were not on appropriate treatments despite information in their records.

Additional features and expanded functionality are expected to roll out in late 2025 and early 2026.

For more information about this news, visit www.pangaeadata.ai.